Rocha Lima CM - Search Results

1

Phase Ib study of drozitumab combined with first-line mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.

Rocha Lima CM, Bayraktar S, Flores AM, MacIntyre J, Montero A, Baranda JC, Wallmark J, Portera C, Raja R, Stern H, Royer-Joo S, Amler LC. Rocha Lima CM, et al. Cancer Invest. 2012 Dec;30(10):727-31. doi: 10.3109/07357907.2012.732163. Epub 2012 Oct 12. Cancer Invest. 2012. PMID: 23061802 Clinical Trial.

2

A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors.

Rocha-Lima CM, Bayraktar S, Macintyre J, Raez L, Flores AM, Ferrell A, Rubin EH, Poplin EA, Tan AR, Lucarelli A, Zojwalla N. Rocha-Lima CM, et al. Cancer. 2012 Sep 1;118(17):4262-70. doi: 10.1002/cncr.27428. Epub 2012 Jan 31. Cancer. 2012. PMID: 22294459 Free article. Clinical Trial.

3

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere.

Soares HP, Bayraktar S, Blaya M, Lopes G, Merchan J, Macintyre J, Mayo C, Green MR, Silva O, Levi J, Walker G, Rocha-Lima CM. Soares HP, et al. Among authors: rocha lima cm. Cancer Chemother Pharmacol. 2014 Apr;73(4):839-45. doi: 10.1007/s00280-014-2414-z. Epub 2014 Feb 23. Cancer Chemother Pharmacol. 2014. PMID: 24562589 Clinical Trial.

4

A phase II trial of nab-Paclitaxel as second-line therapy in patients with advanced pancreatic cancer.

Hosein PJ, de Lima Lopes G Jr, Pastorini VH, Gomez C, Macintyre J, Zayas G, Reis I, Montero AJ, Merchan JR, Rocha Lima CM. Hosein PJ, et al. Among authors: rocha lima cm. Am J Clin Oncol. 2013 Apr;36(2):151-6. doi: 10.1097/COC.0b013e3182436e8c. Am J Clin Oncol. 2013. PMID: 22307213 Clinical Trial.

5

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Hosein PJ, Macintyre J, Kawamura C, Maldonado JC, Ernani V, Loaiza-Bonilla A, Narayanan G, Ribeiro A, Portelance L, Merchan JR, Levi JU, Rocha-Lima CM. Hosein PJ, et al. Among authors: rocha lima cm. BMC Cancer. 2012 May 29;12:199. doi: 10.1186/1471-2407-12-199. BMC Cancer. 2012. PMID: 22642850 Free PMC article.

6

Timing of adjuvant and neoadjuvant therapy in colorectal cancers.

Bayraktar S, Bayraktar UD, Rocha-Lima CM. Bayraktar S, et al. Among authors: rocha lima cm. Clin Colorectal Cancer. 2010 Jul;9(3):144-9. doi: 10.3816/CCC.2010.n.019. Clin Colorectal Cancer. 2010. PMID: 20643618 Review.

7

Advanced or metastatic pancreatic cancer: molecular targeted therapies.

Bayraktar S, Rocha-Lima CM. Bayraktar S, et al. Among authors: rocha lima cm. Mt Sinai J Med. 2010 Nov-Dec;77(6):606-19. doi: 10.1002/msj.20217. Mt Sinai J Med. 2010. PMID: 21105124 Review.

8

Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.

Merchan JR, Ferrell A, Macintyre J, Ciombor KK, Levi J, Ribeiro A, Sleeman D, Flores A, Lopes G, Rocha-Lima CM. Merchan JR, et al. Among authors: rocha lima cm. Am J Clin Oncol. 2012 Oct;35(5):446-50. doi: 10.1097/COC.0b013e31821862fb. Am J Clin Oncol. 2012. PMID: 21552097 Clinical Trial.

9

Emerging cell-cycle inhibitors for pancreatic cancer therapy.

Bayraktar S, Rocha Lima CM. Bayraktar S, et al. Among authors: rocha lima cm. Expert Opin Emerg Drugs. 2012 Dec;17(4):571-82. doi: 10.1517/14728214.2012.739606. Epub 2012 Nov 5. Expert Opin Emerg Drugs. 2012. PMID: 23126234 Review.

10

Molecular basis and management of gastrointestinal stromal tumors.

Bayraktar UD, Bayraktar S, Rocha-Lima CM. Bayraktar UD, et al. Among authors: rocha lima cm. World J Gastroenterol. 2010 Jun 14;16(22):2726-34. doi: 10.3748/wjg.v16.i22.2726. World J Gastroenterol. 2010. PMID: 20533592 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page